Cases & Deals

  • Home
  • Practices
  • Jefferies acts as representative of initial purchasers in $250 million Rule 144A and Regulation S offering by Vantage Oncology, LLC and Vantage Oncology Finance and arranger of revolving credit facility for Vantage Oncology

Share

Jefferies acts as representative of initial purchasers in $250 million Rule 144A and Regulation S offering by Vantage Oncology, LLC and Vantage Oncology Finance and arranger of revolving credit facility for Vantage Oncology

June 2013

Client(s) Jefferies LLC

Jones Day advised Jefferies LLC, as representative of the initial purchasers, in connection with the issuance of $250 million of 9 1/2% Senior Secured Notes due 2017 in a Rule 144A and Regulation S offering by Vantage Oncology, LLC and Vantage Oncology Finance Co., a leading provider of radiation oncology services. Jones Day also advised Jefferies Finance LLC, as arranger, administrative agent, collateral agent, and lender in connection with the concurrent $25 million revolving credit facility for Vantage Oncology.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.